TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LBIOME

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

LBIOME

ST13

US500000079320342

Classe

5, 40, 42

Pedido

79320342

Registro

7033011

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

50

Atualização mais recente

10/01/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 40, 42

Data de depósito

20/05/2021

Data de registro

25/04/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

25/04/2023

Última transação

10/01/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

98

Localização do titular

FR

Examinador

AYALA, LOURDES

Unidade examinadora

L60

Localização atual

PETITIONS OFFICE

Descrição da marca

The mark consists of the stylized wording "LBIOME" and design featuring the letters LB semi-connected and the letter O featured as a circle with ten small ovals, on a tilt, inside the circle.

Titulares e representantes

Titulares

DSM - Firmenich Houdan SAS
Adare Pharmaceuticals SAS

Representantes

Duane M. Byers Nixon & Vanderhye P.C.

Classificação técnica

Classes Nice

Classe 5Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, autisms, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, obsessive-compulsive disorders, addiction, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, necrotizing enterocolitis, enteritis, skin inflammation, and skin infections, and veterinary pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, enteritis, skin inflammation, and skin infections; dietetic foods adapted for medical and veterinary use; bacterial preparations for medical and veterinary use; probiotic bacteria preparations for medical use; foodstuffs and nutritional and food supplements featuring live or inactivated microorganisms, namely, nutritional supplements, enzyme food supplements, dietary food supplements, food supplements for humans and animals; ingredients based on inactive bacteria preparations and heattreated and heat-stabilized bacteria preparations, namely, Lactobacillus strains in combination with fermentation medium featured as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; ingredients based on combinations of inactivated and heat-treated Lactobacillus delbrueckii and Lactobacillus fermentum and fermentation medium sold as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; additives in the nature of dietary supplements for humans or for animals; ferments for medical or veterinary use with postbiotic or probiotic effects

Classe 40

Customized manufacture, for third parties, of pharmaceuticals, nutritional and food supplements featuring live or inactivated microorganisms; manufacture of ingredients comprising inactivated, heat-treated Lactobacillus strains and their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; custom manufacture, for third parties, of pharmaceutical and nutritional supplemental ingredients, namely, enriched culture medium and heat-treated microorganisms; manufacture of pharmaceutical ingredients, namely, heat-treated micro-organisms, for preparation of tablets, capsules, powders, injectable products, suspensions, liquids, for medical and veterinary use

Classe 42

Medical and pharmaceutical research and development in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; scientific research and development; bacteriological scientific research and consultation; provision of information and data relating to medical and veterinary research and development; provision of scientific and technological information in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; design and development of pharmaceuticals, nutritional supplements and dietetic supplements comprising living and inactivated microorganisms; research and development of formulations, namely, pharmaceuticals, nutritional supplements, and dietary supplements for the administration of heat-treated Lactobacillus strains combined with their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; research and development of pharmaceutical ingredients based on enriched culture medium and heat-treated bacteria, namely, Lactobacillus strains; research and development of formulations, namely, pharmaceutials, nutritional supplements, and dietetic supplements, based on enriched culture medium and heat-treated micro-organisms; technological consultation in the field of bacteria-based ingredients and in the field of postbiotics

Publicações

Histórico de despachos e eventos da marca no USPTO.

50 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

15/11/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

19/07/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/11/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/10/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/10/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/10/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

20/08/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/08/2023

FIMP

FINAL DISPOSITION PROCESSED

02/08/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

25/07/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

25/04/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

25/04/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

14/03/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

22/02/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

22/02/2023

CHPB

CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED

07/02/2023

GPNX

NOTIFICATION PROCESSED BY IB

07/02/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/02/2023

PUBO

PUBLISHED FOR OPPOSITION

07/02/2023

APET

ASSIGNED TO PETITION STAFF

01/02/2023

PPAR

POST PUBLICATION AMENDMENT RECEIVED

01/02/2023

APET

ASSIGNED TO PETITION STAFF

30/01/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

18/01/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

18/01/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

18/01/2023

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

17/01/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/12/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/12/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

30/12/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/09/2022

GNFR

FINAL REFUSAL E-MAILED

03/09/2022

CNFR

FINAL REFUSAL WRITTEN

03/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/08/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/08/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/08/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

26/07/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

26/07/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

26/07/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

26/07/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

26/07/2022

RFNT

REFUSAL PROCESSED BY IB

27/03/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/03/2022

RFRR

REFUSAL PROCESSED BY MPU

09/03/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/02/2022

CNRT

NON-FINAL ACTION WRITTEN

10/02/2022

DOCK

ASSIGNED TO EXAMINER

01/02/2022

MAFR

APPLICATION FILING RECEIPT MAILED

28/09/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/09/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

16/09/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LBIOME ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.